|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1503 W 9th St. |
Address2 | #201 |
City | Austin |
State | TX |
Zip Code | 78703 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401104328-12
|
||||||||
|
6. House ID# 435440001
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Cameron Krier Massey |
Date | 7/20/2023 10:58:20 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Support HR 2665, the Supporting Safety Net Hospitals Act, which would repeal cuts to the Medicaid Disproportionate Share Hospital Program.
Support for congressional House sign-on letter to leadership asking them to address the cuts to the Medicaid Disproportionate Share Hospital Program.
Request congressional engagement on Informational Bulletin released by CMS on February 17, 2023 related to permissible state financing arrangements in the Medicaid program.
Oppose the Emergency Care Improvement Act (HR 1694), legislation related to free-standing emergency centers and participation as a Medicare provider.
Oppose H.R. 3281, the Transparent PRICE Act, which would require additional reporting by hospitals on pricing.
Oppose H.R. 3290, which requires additional reporting by hospitals participating in the 340B program.
Oppose H.R. 3262, which requires new reporting by hospitals about ownership structure.
Oppose H.R. 3237, which implements a site-neutral payment policy for drugs administered at off-campus hospital outpatient departments.
Oppose site-neutral payment policies (generally) that reduce payments to hospitals for services delivered at off-campus hospital outpatient departments.
Provide comments to CMS on CMS-2445-P Medicaid Program; Disproportionate Share Hospital Third-Party Payer Rule; provisions related to Hospital-Specific DSH Payment Limit ( 447.295) and Limitations on Aggregate Payments for DSHs Beginning October 1, 1992 ( 447.297).
Provide comments to CMS on CMS-1788-P Medicare Program; Medicare Disproportionate Share Hospital (DSH) Payments: Counting Certain Days Associated With Section 1115 Demonstrations in the Medicaid Fraction; opposing a proposal to eliminate section 1115 demonstration waiver inpatient days that are associated with uncompensated care pools.
Provide comments to CMS on CMS-1785-P CMS-1785-P, Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2024 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Rural Emergency Hospital and Physician-Owned Hospital Requirements; and Disclosure of Ownership; provisions related to IPPS payments to hospitals, funding for medical residents at Rural Emergency Hospitals, and others.
Provide comments to CMS on CMS-2439-P, CMS-2439-P, Medicaid Program; Medicaid and Childrens Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality; opposing limitations on state directed payment programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cameron |
Krier Massey |
|
Legislative counsel for former US Senator Kay Bailey Hutchison |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |